Table 2.
Group | CR | PR | SD | χ2 | P |
---|---|---|---|---|---|
C group | 34 (29.82) | 54 (47.37) | 26 (22.81) | 15.53 | 0.004 |
SR group | 33 (30.28) | 59 (54.13) | 17 (15.60) | ||
C+SR group | 43 (40.57) | 58 (54.72) | 5 (4.72) |
NPC – nasopharyngeal carcinoma; CT – chemotherapy; SRT – stereotactic radiotherapy; CR – complete response; PR – partial response; SD – disease stable.